Grant scheme:

Horizont2020

DG:

REA

Name of the project:

ALGAE4IBD – FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

Project ID:

101000501

Aim of the project:

To address the unmet need in tackling IBD, we intend to use a multi-disciplinary approach to identify bioactive molecules from a botanical source and verify the beneficial claim for IBD prevention and treatment with an innovative technology based on algae. Algae4IBD will perform a detailed research from lab/pilot to market scale to identify how aquatic natural biological resources can be transformed into biologically active compounds to be used for IBD prevention and treatment while preserving the biodiversity of the renewable source

Partners involved:

COORDINATOR

Organisation – MIGAL GALILEE RESEARCH INSTITUTE LTD – MIGAL – Galilee research Institute

BENEFICIARY Organisations

YEMOJA LTD

NORD UNIVERSITET – NORD UNIVERSITET

CENTRO DE CIENCIAS DO MAR DO ALGARVE – CCMAR

ALGAIA

TEAGASC – AGRICULTURE AND FOOD DEVELOPMENT AUTHORITY

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II – UNINA

SOLARIS LAB SRL

SZEGEDI BIOLOGIAI KUTATOKOZPONT – BIOLOGICAL RESEARCH CENTRE

VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V. – VITO

MIKROBIOLOGICKY USTAV AV CR V.V.I

EUROPEAN SCIENCE COMMUNICATION INSTITUTE (ESCI) GGMBH

ELOOP SRL

HUMANITAS UNIVERSITY – HUNIMED

NECTON – COMPANHIA PORTUGUESA DE CULTURAS MARINHAS SA

ENCO SRL – ENCO SRL

GOPSIS LDA

SLOVENSKA POLNOHOSPODARSKA UNIVERZITA V NITRE – SLOVAK UNIVERSITY OF AGRICULTURE IN NITRA

SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA – SEA4US

SYNOVO GMBH – Synovo

USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE – UMG AV CR, v. v. i.